SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-07-000685
Filing Date
2007-03-12
Accepted
2007-03-12 16:57:52
Documents
4
Period of Report
2007-01-31

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10q-013107.htm 10-Q 1010589
2 SECTION 302 CERTIFICATION OF CEO peregrine_10q-ex3101.htm EX-31.1 11793
3 SECTION 302 CERTIFICATION OF CFO peregrine_10q-ex3102.htm EX-31.2 12278
4 SECTION 906 CERTIFICATION OF CEO & CFO peregrine_10q-ex3200.htm EX-32 12475
  Complete submission text file 0001019687-07-000685.txt   1048734
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 07688320
SIC: 2835 In Vitro & In Vivo Diagnostic Substances